New Images from NCI Visuals Online

New Images from NCI Visuals Online

Advancing Public Health in Cancer
09/24/2018
	NCI’s investments in cancer control, population health, and survivorship are aimed at reducing cancer risk, incidence, and mortality and on improving the quality of life of cancer survivors and the general population.

Balloon Device Helps Detect Barrett Esophagus
09/24/2018
	This illustration shows how a swallowable balloon device helps detect Barrett esophagus, a condition that may confer a low risk of esophageal cancer.

CAR T-Cell Therapy
09/24/2018
	This schematic shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.

CAR T-Cell Therapy Clinical Trials
09/24/2018
	There are hundreds of clinical trials underway studying CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.

Cancer Deaths Averted 1991-2015
09/24/2018
	The total number of cancer deaths averted in men and women from 1991 to 2015 was 2,378,600.

Cancer and the Human Tumor Atlas Network
09/24/2018
	Information mapped in human tumor atlases will provide a comprehensive understanding of the ecosystem of tumors and show important transitions in cancer.

Deaths from Cancer: Rural vs Urban
09/24/2018
	This illustration shows the age-adjusted cancer mortality rate in rural and urban U.S. populations, stratified into six different population sizes.

Deaths from Cancer: Rural vs Urban
09/24/2018
	Among U.S. women age 40-74, 40% to 50% have dense breasts. Women with dense breasts have a higher risk of breast cancer.

Detecting and Diagnosis Cancer
09/24/2018
	As has been true for many years, NCI continues to support a broad portfolio of research aimed at improving the early detection and diagnosis of cancer and its precursors.

FAP and Cancer Risk
09/24/2018
	People with familial adenomatous polyposis (FAP) have a 100% lifetime risk of colon cancer.

Leading Cancer Research
09/24/2018
	NCI’s mission is to lead, conduct, and support cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.

Merit: R37 Award
09/24/2018
	The NCI Method to Extend Research in Time (MERIT) (R37) Award provides longer term grant support to early stage investigators. This graph shows that R01 awards provide 5 years of funding versus R37 awards, which provide 7 years of funding.

NCI Cancer Centers Diagnosis
09/24/2018
	NCI Cancer Centers diagnose 250,000 cancer cases each year.

NCI Key Focus Area: Basic Science
09/24/2018
	Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.

NCI Key Focus Area: Big Data
09/24/2018
	Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.

NCI Key Focus Area: Clinical Trials
09/24/2018
	Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.

NCI Key Focus Area: Workforce Development
09/24/2018
	Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.

National Cancer Data Ecosystem
09/24/2018
	To advance precision medicine in cancer care, a National Cancer Data Ecosysem is necessary.

Number of New Cancer Cases and Deaths Each Year
09/24/2018
	This graph shows the number of new U.S. cancer cases and deaths each year per 100,000 persons by race/ethnicity and sex.

Partners in Cancer Research
09/24/2018
	Dr. Ned Sharpless, director of the National Cancer Institute, with Mike, a patient he treated for acute leukemia. Cancer patients like Mike are NCI's true partners in cancer research.